Biocardia, INC S-1 registration statements

BioCardia, Inc. filed an amendment to its S-1 registration statement, primarily updating its engagement agreement with H.C. Wainwright & Co., LLC for capital raising services and delaying the effective date.

BioCardia, Inc. is offering up to 2.8 million shares and warrants to raise $5.3 million, aiming to fund clinical trials and operations while facing a Nasdaq compliance deadline.

BioCardia, Inc. has filed a registration statement to offer an additional $1.2 million in common stock, pre-funded warrants, and accompanying common warrants.

BioCardia, Inc. announces a best efforts offering to raise up to $5.3 million through the sale of common stock, pre-funded warrants, and common warrants to fund working capital and general corporate purposes.

BioCardia, Inc. files for a best efforts public offering of common stock, pre-funded warrants, and common warrants to raise capital for general corporate purposes.